Updated: Johnson & Johnson (NYSE:JNJ) is pulling the plug on its troubled metal-on-metal hip implant business, effective Aug. 31. In a statement released by JNJ subsidiary DePuy Orthopaedics, the healthcare giant said it would halt all sales of its Ultamet metal-on-metal articulation and Complete ceramic-on-metal acetabular hip system because … Read More
Updated: DePuy executives are in a Los Angeles, Calif., courtroom battling a lawsuit that could launch literally thousands more civil cases against the orthopedic device maker. The lawsuit – Sandra Ellis, Loren Kransky, et al. v. DePuy Inc., et al. – is the first against DePuy to go before … Read More
Updated: One year after Johnson & Johnson pulled 93,000 metal hip implants from the market, the company internally estimated that 37 percent of the devices would fail within 4.6 years, according to newly unsealed court records. J&J faces 10,000 lawsuits over its ASR hips, which it pulled in August … Read More
